Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-010823

CHIEF MEDICAL OFFICER sold 20,000 shares at $25.07 ($501,478)

  • CHIEF MEDICAL OFFICER acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Collins Helen Louise · CHIEF MEDICAL OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-11 Exercise or conversion : show line 1 in the form 10b5-1 +20,000 $2.48 $49,600 20,000 D
2024-04-11 Sale : show line 2 in the form 10b5-1 −20,000 $25.07 $501,478 0 D
Open-market sales · 20,000 sh · avg $25.07 · $501,478

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-11 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −20,000 267,084 D
Loading xslF345X05/form4-04152024_110437.xml…